Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations Meeting Abstract
| Authors: | Hollebecque, A.; Borad, M.; Sahai, V.; Catenacci, D. V. T.; Murphy, A.; Vaccaro, G.; Paulson, A.; Oh, D. Y.; Féliz, L.; Lihou, C.; Zhen, H.; Abou-Alfa, G. K. |
| Abstract Title: | Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | 258 |
| Language: | English |
| ACCESSION: | WOS:000459277301335 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy282.139 |
| Notes: | Meeting Abstract: 756P -- Appears on page viii258 of the abstract book -- Source: Wos |
